tirzepatide off label is a novel medication that the FDA has approved for treating type 2 diabetes mellitus. Due to its potent weight loss properties, Tirzepatide can be used off-label for treating obesity. The Off-label use of semaglutide and

Ocular migraines: Potentially triggered by stress, hormonal changes, or medications affecting blood vessels, Rybelsus patients may experience migraines involving visual disturbances such as flashing lights, zigzag patterns, or temporary vision loss

Even if studies do not query subjects for heartburn and reflux and most dont all GI GLP-1 side-effects lead to acid reflux, both esophageal reflux and respiratory reflux

When Eli Lilly first reported their results, the share prices of some fast-food places dipped, said Sattar

Studies show most patients regain part of the lost weight and see A1C drift upward within 3-6 months